Generated: May 23, 2017
|Title:||Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors|
|Abstract:||A pharmaceutical formulation comprising the compound of formula ##STR00001##|
|Inventor(s):||Carter; Malcolm Clive (Stevenage, GB), Cockerill; George Stuart (Stevenage, GB), Lackey; Karen Elizabeth (Durham, NC)|
|Assignee:||GlaxoSmithKline LLC (Philadelphia, PA)|
|Filing Date:||Jul 16, 2013|
|Claims:||1. A pharmaceutical formulation presented in unit dose form comprising the compound of formula ##STR00055## as an active ingredient, wherein said active ingredient s present within said unit dose form in an amount from 70 mg to 700 mg. |
2. The formulation of claim 1, wherein said unit dose is a tablet.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.